The strong effect of the anti-IL-17A Ab on PDL1 expression in murine tumor cells, macrophages, and MDSCs prompted us to further investigate whether targeting of IL-17A could transform the tumor microenvironment. The gene discussed is IL17A; the disease is neoplasm.